JUN 14, 2018 03:10 PM PDT

The Rise of Carbapenem Resistance

WRITTEN BY: Carmen Leitch
2 14 249

European scientists are warning about the rise of a dangerous group of microbes that resist the effects of an important class of drugs called carbapenems. These drugs, which include doripenem, ertapenem, imipenem, and meropenem, work against many different kinds of pathogenic microbes and are used when other drugs fail. However, bacteria are becoming resistant to them; such pathogens are now thought to pose a significant threat to the patients in the healthcare clinics of every country in the European Union. A Rapid Risk Assessment about these conclusions has been released by the European Centre for Disease Prevention and Control. 

First reported in the nineties, resistance to carbapenems has since become more common and spread to more areas of the globe. It’s one type of bacteria, Enterobacteriaceae, that is gaining the upper hand on the drugs, as they become carbapenem-resistant Enterobactericaeae, or simply CRE. CRE infections pose a real danger.

"We should be very concerned about the rise in carbapenem resistance in the EU/EEA as there are very few options for the treatment of patients with CRE infections,” said Dominique Monnet, the Head of ECDC's Antimicrobial Resistance and Healthcare-Associated Infections Programme. "In recent years, the proportions of carbapenem resistance in Klebsiella pneumoniae - a type of Enterobacteriaceae - rapidly increased to high levels in Greece, Italy, and Romania. The same could happen to other EU/EEA countries if appropriate measures are not taken. But the spread of CRE can likely be controlled in most countries through the implementation of appropriate prevention and control measures in hospitals and other healthcare settings."

CRE infections of the bloodstream and urinary tract are not unusual in hospitals, and they can make a patient's stay in the hospital longer and increase the cost of treating patients. They can also contribute to failures in treatment and cause death; treating these infections is challenging, and there are limited options, especially for patients in hospitals.
 
While the prevalence of these infections is still low, in Europe the national percentages of bloodstream infections caused by Klebsiella pneumonia that is carbapenem-resistant ranges from zero to 67 percent. The highest rates are in Romania, Italy, and Greece; those countries have rates of 31, 34 and 67 percent, respectively.

When antibiotic resistance becomes a frequent occurrence, that antibiotic ceases to be recommended for use. There aren’t any antibiotics that are a good choice for fighting a CRE infection. 

Global travel and patient transfer can introduce CRE into new countries or countries where the prevalence is low. Some places, like Southeast Asia and India, have high levels of CRE.

Enterobacteriaceae / Credit: Pixnio

It will be important for clinics to monitor for these infections carefully, and to mount an effective response when they occur. The ECDC's Rapid Risk Assessment highlights steps doctors can take.

 

Sources: AAAS/Eurekalert! via ECDC, Merck Manuals

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAY 16, 2018
Microbiology
MAY 16, 2018
The Structure of a Bacterial Protein Supercomplex is Revealed
Researchers isolated a supercomplex that acts as a kind of battery and helps generate energy for bacteria.
MAY 22, 2018
Cancer
MAY 22, 2018
Breakthrough Analysis Outlines Conceivable Cause of Childhood ALL
A team from the Institute of Cancer Research has published a comprehensive literature review and outlined a breakthrough in the causative theory of childhood ALL development.
MAY 31, 2018
Microbiology
MAY 31, 2018
Ulcer-causing Microbe Found to Disrupt Mitochondria
Knowing how H. pylori establishes an infection will help develop better treatments for the pathogen.
JUN 12, 2018
Genetics & Genomics
JUN 12, 2018
Giant Viruses can Make Their own Genes
Researchers have discovered something incredible about giant viruses.
AUG 02, 2018
Genetics & Genomics
AUG 02, 2018
The Genetic Hotspots That Can Lead to Cancer
In some of our body's tissues, cells have to replicate many times. That introduces a chance for new genetic errors every time.
AUG 13, 2018
Immunology
AUG 13, 2018
Silent Viruses Impact Microbe and Immune Cell Populations
Subclinical infections may alter the immune system and gut microbiota in the human host impacting how we respond to environmental stimuli like vaccines.
Loading Comments...